Skip to main content
Fig. 4 | Trials

Fig. 4

From: Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations

Fig. 4

Relative importance of site-related qualities for early phase (a) and phase III trials (b)* * Respondents (n = 83) were asked which of five site-related qualities their company finds the most important during site selection for an early phase clinical trial and phase III clinical trial, respectively. The five response categories were ranked from one to five, one being the most important. MR mean ranking (of the response category), SD standard deviation

Back to article page

Trials

ISSN: 1745-6215